133 related articles for article (PubMed ID: 12429601)
1. Magnetic resonance spectroscopy and cognitive function in healthy elderly men.
Ferguson KJ; MacLullich AM; Marshall I; Deary IJ; Starr JM; Seckl JR; Wardlaw JM
Brain; 2002 Dec; 125(Pt 12):2743-9. PubMed ID: 12429601
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
3. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
Waldman AD; Rai GS
Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cognitive functions of juvenile myoclonic epileptic patients by magnetic resonance spectroscopy and neuropsychiatric cognitive tests concurrently.
Cevik N; Koksal A; Dogan VB; Dirican AC; Bayramoglu S; Ozturk M; Baybas S
Neurol Sci; 2016 Apr; 37(4):623-7. PubMed ID: 26603049
[TBL] [Abstract][Full Text] [Related]
6. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
7. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal region metabolites and cognitive impairment in patients with general paresis: based on
Che X; Miao T; Shi H; Li Z; Ning Y
Front Pharmacol; 2024; 15():1382381. PubMed ID: 38694926
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
[TBL] [Abstract][Full Text] [Related]
10. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
12. Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: A proton magnetic resonance spectroscopy study.
Lai S; Zhong S; Liao X; Wang Y; Huang J; Zhang S; Sun Y; Zhao H; Jia Y
J Affect Disord; 2018 Jan; 225():108-116. PubMed ID: 28818755
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.
Kantarci K; Lowe V; Przybelski SA; Senjem ML; Weigand SD; Ivnik RJ; Roberts R; Geda YE; Boeve BF; Knopman DS; Petersen RC; Jack CR
Neurology; 2011 Sep; 77(10):951-8. PubMed ID: 21865577
[TBL] [Abstract][Full Text] [Related]
15. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
16. [Correlates of cognitive impairment in patients with leukoaraiosis by magnetic resonance spectroscopy].
Yuan JL; Wang SK; Guo XJ; Peng P; Gu H; Zhao WH; Niu SQ; Hu WL
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):303-6. PubMed ID: 22490831
[TBL] [Abstract][Full Text] [Related]
17. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical Changes in the Brain and Neuropsychiatric Symptoms in Clinically Isolated Syndrome.
Guenter W; Bieliński M; Bonek R; Borkowska A
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33276455
[TBL] [Abstract][Full Text] [Related]
19. Experimental hypoxic-ischemic encephalopathy: comparison of apparent diffusion coefficients and proton magnetic resonance spectroscopy.
Li YK; Liu GR; Zhou XG; Cai AQ
Magn Reson Imaging; 2010 May; 28(4):487-94. PubMed ID: 20071123
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy.
Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K
J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
